Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma

Leuk Lymphoma. 2019 Dec;60(14):3581-3583. doi: 10.1080/10428194.2019.1633637. Epub 2019 Jun 27.

Authors

Talal Hilal¹, Alanna Maguire², Heidi E Kosiorek³, Lisa M Rimsza⁴, Allison C Rosenthal¹

Affiliations

¹ Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
² Department of Research, Mayo Clinic, Phoenix, AZ, USA.
³ Department of Statistics, Mayo Clinic, Phoenix, AZ, USA.
⁴ Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Phoenix, AZ, USA.

PMID: 31246148
DOI: 10.1080/10428194.2019.1633637

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor / genetics*
Central Nervous System Neoplasms / genetics
Central Nervous System Neoplasms / pathology*
Combined Modality Therapy
Female
Follow-Up Studies
Gene Expression Profiling*
Gene Expression Regulation, Neoplastic
HIV / isolation & purification
HIV Infections / virology*
Humans
Lymphoma, Non-Hodgkin / genetics
Lymphoma, Non-Hodgkin / pathology*
Male
Middle Aged
Prognosis
Retrospective Studies
Survival Rate

Substances

Biomarkers, Tumor